Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients Treated With Calcineurin Inhibitors

NCT00611494 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Organ Transplantation

Interventions

DRUG: MMF
DRUG: EC-MPS

Sponsor

University Health Network, Toronto